Department of Pediatrics, Division of Neonatology, Golisano Children's Hospital at Strong, University of Rochester, Rochester, New York 14642, USA.
JPEN J Parenter Enteral Nutr. 2010 Jul-Aug;34(4):414-20. doi: 10.1177/0148607110362529.
The author has previously shown that intravenous lipid intake may be associated with an increase in unbound bilirubin in infants < or =28 weeks gestational age. The objective of this study was to evaluate whether this increase in unbound bilirubin is mediated by free fatty acids and to examine the secondary effect of free fatty acids on bilirubin-albumin binding affinity.
A prospective study was conducted to include 26 infants < or =32 weeks gestational age with indirect hyperbilirubinemia and receiving intravenous lipids during the first 10 postnatal days. Blood samples were collected for unbound bilirubin, binding affinity, and free fatty acid measurement at varying intravenous lipid intakes (1-3 g/kg/d). Regression analyses were performed to evaluate the roles of free fatty acids and binding affinity as mediators.
Intravenous lipid intake was significantly associated with an increase in free fatty acids and unbound bilirubin in infants < or =28 weeks but not >28 weeks gestational age. In infants < or =28 weeks gestational age, each unit increase in free fatty acids was significantly associated with a decrease in binding affinity, which was significantly associated with an increase in unbound bilirubin.
In infants < or =28 weeks gestational age, intravenous lipid intake may be associated with an increase in unbound bilirubin, and this is mediated by an increase in free fatty acids and a secondary decrease in binding affinity. In infants >28 weeks gestational age, higher intravenous lipid intake may be used because it is unassociated with increases in free fatty acids and unbound bilirubin.
作者先前已经表明,静脉内脂肪摄入可能与<或=28 周胎龄婴儿的未结合胆红素增加有关。本研究的目的是评估这种未结合胆红素的增加是否是由游离脂肪酸介导的,并检查游离脂肪酸对胆红素-白蛋白结合亲和力的次级影响。
进行了一项前瞻性研究,纳入了 26 名<或=32 周胎龄、有间接高胆红素血症且在出生后 10 天内接受静脉内脂肪的婴儿。在不同的静脉内脂肪摄入量(1-3 g/kg/d)时采集血液样本,用于测量未结合胆红素、结合亲和力和游离脂肪酸。进行回归分析以评估游离脂肪酸和结合亲和力作为中介的作用。
静脉内脂肪摄入与<或=28 周胎龄婴儿的游离脂肪酸和未结合胆红素的增加显著相关,但与>28 周胎龄婴儿的游离脂肪酸和未结合胆红素的增加不相关。在<或=28 周胎龄的婴儿中,每单位游离脂肪酸的增加与结合亲和力的降低显著相关,而结合亲和力的降低与未结合胆红素的增加显著相关。
在<或=28 周胎龄的婴儿中,静脉内脂肪摄入可能与未结合胆红素的增加有关,这是由游离脂肪酸的增加和结合亲和力的继发性降低介导的。在>28 周胎龄的婴儿中,更高的静脉内脂肪摄入可能是因为它与游离脂肪酸和未结合胆红素的增加无关。